Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

DGICB vs HIPO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

DGICB Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)

DGICB Overall Winner 6-Pillar Tally: DGICB 3 – 3 HIPO Matrix Metrics: DGICB 6 – 4 HIPO

As of Nov 16, 2026, DGICB (DGICB) is the stronger overall head-to-head candidate over Hippo Holdings Inc. (HIPO) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DGICB carries a Unified Composite Score of 30.8/100 (SELL) at $28.55 (14.4x Forward P/E, 9.0% operating margin), whereas HIPO carries 47.0/100 (HOLD) at $37.92 (10.2x Forward P/E, 6.6% operating margin).

  • Composite vs. Pillar Nuance: While HIPO currently prints a higher short-term Unified Composite Score (47.0/100 HOLD vs. DGICB 30.8/100 SELL), DGICB captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (9.0% vs. 6.6% operating margin) and revenue trajectory (-3.4% vs. +29.4% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DGICB vs HIPO
DGICB US Equity Head-to-Head Winner
DGICB
Institutional Equity
$28.55
+1.21% 1D
Market Cap $1.1B
TTM Revenue $955M
Forward P/E 14.4x
Beta / 30D Vol 0.27β · 86% Vol
Unified Composite Score
30.8 / 100 SELL
Tech 5.0 Fund 27.0 Flow 50.0 Mom 31.5
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.2% over 20 days), RSI 67
RSI-14: 66.6 · SMA20: $25.16 · SMA50: $21.89
HIPO NYSE
Hippo Holdings Inc.
Fire, Marine & Casualty Insurance
$37.92
+1.91% 1D
Market Cap $990.6M
TTM Revenue $543M
Forward P/E 10.2x
Beta / 30D Vol 0.51β · 32% Vol
Unified Composite Score
47.0 / 100 HOLD
Tech 25.0 Fund 48.0 Flow 67.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.7% over 20 days), RSI 65
RSI-14: 64.7 · SMA20: $36.92 · SMA50: $34.23

6-Pillar Scorecard Institutional Category Breakdown (DGICB 3 – 3 HIPO)

Columns: Metric · DGICB · HIPO
1. Valuation Multiples DGICB
Forward P/E 14.4x 10.2x
Trailing P/E 15.2x 30.2x
PEG Ratio 1.90x N/M
EV / Revenue 1.1x 1.3x
2. Growth & Scale DGICB
Revenue Growth (YoY) -3.4% +29.4%
Earnings Growth (YoY) -11.3% -91.2%
TTM Revenue (USD) $955M $543M
Market Cap $1.1B $990.6M
3. Profitability & Quality DGICB
Gross Margin 9.2% 58.4%
Operating Margin 9.0% 6.6%
Net Profit Margin 7.2% 5.9%
Return on Equity (ROE) 10.7% 7.2%
4. Balance Sheet & Cash Flow HIPO
Cash Generation (TTM) $88M EBITDA $114M
Cash Flow Margin 9.2% EBITDA Mgn 21.0%
Net Cash / Leverage $17.70 Book/Sh · 10.7% ROE $261M Net Cash
Dividend Yield 2.69% None (0.00%)
5. Options & Positioning HIPO
Options Structure Phase UNCLASSIFIED BREAKOUT
Current IV / %ile N/A (N/A) 67.7% (7th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup ACCUMULATION · Markup
6. R&D & Supply-Chain Moat HIPO
OpEx & R&D Intensity N/A 51.8% of Rev ($281M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance - Property & Casualty Operator Insurance - Property & Casualty Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DGICB (6) vs HIPO (4)
Institutional Metric DGICB HIPO Criterion Row Edge
Market Capitalization
Scale
$1.1B $990.6M Larger Scale DGICB
Trailing P/E Ratio
Valuation
15.2x 30.2x Lower Multiple DGICB
Forward P/E Ratio
Valuation
14.4x 10.2x Lower Multiple HIPO
Revenue Growth (YoY)
Growth
-3.4% +29.4% Higher Growth HIPO
Operating Margin (TTM)
Profitability
9.0% 6.6% Higher Margin DGICB
Net Profit Margin
Profitability
7.2% 5.9% Higher Margin DGICB
Return on Equity (ROE)
Capital Efficiency
10.7% 7.2% Higher ROE DGICB
52-Week Range Position
Momentum
91% ($14–$30) 90% ($24–$39) Stronger Trend DGICB
Beta / 30D Volatility
Risk Regime
0.27β · 86% Vol 0.51β · 32% Vol Lower Realized Risk HIPO
Unified Institutional Score
Composite Signal
30.8 / 100 (SELL) 47.0 / 100 (HOLD) Higher Composite HIPO
Trailing 12M Revenue (USD)
Operating Scale
$955M $543M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
9.2% 58.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.90x PEG · 1.1x EV/Rev N/M PEG · 1.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$88M EBITDA ($17.70 Book/Sh · 10.7% ROE) $114M ($261M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DGICB +41.55 pp
DGICB: +49.09% · HIPO: +7.54%
3M Horizon DGICB +3.25 pp
DGICB: +30.37% · HIPO: +27.12%
6M Horizon DGICB +16.5 pp
DGICB: +63.14% · HIPO: +46.64%
1Y Horizon DGICB +60.83 pp
DGICB: +77.72% · HIPO: +16.89%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DGICB vs HIPO. Trailing 12-month operating profitability (DGICB 9.0% vs HIPO 6.6%) and valuation multiples (DGICB 14.4x vs HIPO 10.2x Forward P/E) are benchmarked directly in Pillar 4 below.

DGICB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$955M
Gross Margin9.2%
Op. Margin9.0%
ROE / Fwd P/E10.7% · 14.4x
HIPO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$543M
Gross Margin58.4%
Op. Margin6.6%
ROE / Fwd P/E7.2% · 10.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DGICB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DGICB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HIPO BREAKOUT
58d in phase · OBV ACCUMULATION
Current IV 67.7%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact HIPO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DGICB Moat Profile Cyclical / Execution-Driven Positioning
Insurance - Property & Casualty Operator
Competes within the Insurance - Property & Casualty value chain with $1.1B market capitalization and 9.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HIPO Moat Profile Cyclical / Execution-Driven Positioning
Insurance - Property & Casualty Operator
Competes within the Insurance - Property & Casualty value chain with $990.6M market capitalization and 6.6% operating margin.
OpEx & R&D Reinvestment 51.8% of Rev ($281M)
90D Engineering Disclosures 0 Published

Investor FAQ DGICB vs HIPO Key Questions & Quantitative Answers

As of Nov 16, 2026, DGICB (DGICB) is the stronger overall head-to-head candidate over Hippo Holdings Inc. (HIPO) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DGICB carries a Unified Composite Score of 30.8/100 (SELL) at $28.55 (14.4x Forward P/E, 9.0% operating margin), whereas HIPO carries 47.0/100 (HOLD) at $37.92 (10.2x Forward P/E, 6.6% operating margin). Composite vs. Pillar Nuance: While HIPO currently prints a higher short-term Unified Composite Score (47.0/100 HOLD vs. DGICB 30.8/100 SELL), DGICB captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (9.0% vs. 6.6% operating margin) and revenue trajectory (-3.4% vs. +29.4% YoY).

DGICB leads the Growth & Scale pillar: DGICB posts -3.4% YoY revenue growth and -11.3% YoY earnings growth on $955M TTM revenue (9.2% gross margin, 9.0% operating margin), compared with HIPO at +29.4% YoY revenue growth and -91.2% YoY earnings growth on $543M TTM revenue (58.4% gross margin, 6.6% operating margin). On trailing 12-month operating scale, DGICB generates $955M in USD-normalized revenue versus $543M for HIPO. In operating R&D and SG&A reinvestment, DGICB deploys N/A (0 90-day corporate R&D disclosures) versus 51.8% of Rev ($281M) (0 disclosures) for HIPO.

DGICB screens cheaper on headline valuation multiples. DGICB trades at 14.4x Forward P/E, 15.2x Trailing P/E, 1.90x PEG, and 1.1x EV/Revenue (9.2% EBITDA margin), whereas HIPO trades at 10.2x Forward P/E, 30.2x Trailing P/E, N/M PEG, and 1.3x EV/Revenue (21.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DGICB (10.7% ROE) versus HIPO (7.2% ROE) capital efficiency.

In options market volatility and institutional positioning, DGICB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.27β · 86% Vol realized risk). By comparison, HIPO carries 67.7% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (0.51β · 32% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.